OLIX PHARMACEUTICALS, INC. financial statements, including revenue, expenses, and profit
The total revenue of 226950 for the last quarter is 45.21 M KRW, and it's 82.86% lower compared to the previous quarter. The net income of Q4 24 is -12.16 B KRW.